Healthequity (HQY) Rating Reiterated by Chardan Capital
Chardan Capital reaffirmed their buy rating on shares of Healthequity (NASDAQ:HQY) in a report published on Thursday morning, MarketBeat.com reports. The firm currently has a $78.00 price objective on the stock, down from their previous price objective of $82.00.
A number of other brokerages have also recently commented on HQY. Zacks Investment Research cut Healthequity from a buy rating to a hold rating in a report on Tuesday, December 18th. Cantor Fitzgerald increased their target price on Healthequity from $80.00 to $82.00 and gave the company a neutral rating in a report on Thursday, December 6th. ValuEngine cut Healthequity from a buy rating to a hold rating in a report on Saturday, December 15th. SunTrust Banks upgraded Healthequity from a hold rating to a buy rating and set a $81.00 target price on the stock in a report on Thursday. Finally, BidaskClub cut Healthequity from a buy rating to a hold rating in a report on Tuesday, November 20th. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Healthequity presently has an average rating of Buy and an average price target of $89.62.
HQY opened at $71.66 on Thursday. The company has a market capitalization of $4.47 billion, a P/E ratio of 132.70, a PEG ratio of 2.41 and a beta of 1.64. Healthequity has a 1-year low of $47.33 and a 1-year high of $101.58.
In related news, Director Frank Corvino sold 1,778 shares of the stock in a transaction on Monday, December 10th. The stock was sold at an average price of $67.78, for a total value of $120,512.84. Following the transaction, the director now directly owns 5,051 shares of the company’s stock, valued at approximately $342,356.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $76.91, for a total value of $307,640.00. Following the completion of the transaction, the vice president now directly owns 89,500 shares in the company, valued at $6,883,445. The disclosure for this sale can be found here. Insiders have sold 15,846 shares of company stock worth $1,058,948 in the last 90 days. Insiders own 4.00% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of the stock. Ffcm LLC purchased a new position in Healthequity in the fourth quarter valued at about $122,000. AGF Investments Inc. raised its position in Healthequity by 42.9% in the fourth quarter. AGF Investments Inc. now owns 100,000 shares of the company’s stock valued at $5,965,000 after purchasing an additional 30,000 shares during the period. Massachusetts Financial Services Co. MA purchased a new position in Healthequity in the fourth quarter valued at about $15,455,000. BlackRock Inc. raised its position in Healthequity by 1.6% in the fourth quarter. BlackRock Inc. now owns 6,764,271 shares of the company’s stock valued at $403,489,000 after purchasing an additional 109,127 shares during the period. Finally, Institute for Wealth Management LLC. purchased a new position in Healthequity in the fourth quarter valued at about $507,000. 94.07% of the stock is currently owned by institutional investors and hedge funds.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: Float
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.